moatshark My

All holdings

CVS Health

CVS

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Managers holding
5
In their latest 13F (Q3 2026)
See who
Value held
$6.7bn
Combined value at quarter end
Last quarter
0 bought
4 sold or trimmed
Fund portfolios
2
Funds holding it
See which
Price at Q3 ’26 end
$85.69
-17.2% in the quarter

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Share price change by quarter

-28.6%Q4 ’24
+50.9%Q1 ’25
+1.8%Q2 ’25
+9.3%Q3 ’25
+5.3%Q4 ’25
-9.5%Q1 ’26
+44.0%Q2 ’26
-17.2%Q3 ’26
Q4 ’24: -28.6%; Q1 ’25: +50.9%; Q2 ’25: +1.8%; Q3 ’25: +9.3%; Q4 ’25: +5.3%; Q1 ’26: -9.5%; Q2 ’26: +44.0%; Q3 ’26: -17.2%

Change in the quarter-end price implied by managers’ 13F filings, adjusted for stock splits. Excludes dividends.

Managers holding it, by quarter

7Q4 ’23
7Q1 ’24
6Q2 ’24
5Q3 ’24
5Q4 ’24
5Q1 ’25
6Q2 ’25
6Q3 ’25
6Q4 ’25
6Q1 ’26
5Q2 ’26
1Q3 ’26
Q4 ’23: 7; Q1 ’24: 7; Q2 ’24: 6; Q3 ’24: 5; Q4 ’24: 5; Q1 ’25: 5; Q2 ’25: 6; Q3 ’25: 6; Q4 ’25: 6; Q1 ’26: 6; Q2 ’26: 5; Q3 ’26: 1

Counts the managers on this site whose 13F for that quarter includes CVS Health.

Who holds it

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Managers holding CVS Health
Fairfax Financial Holdings10.6%$281m$281mUnchanged7 qtrs
Davis Selected Advisers5.3%$1.2bn$1.2bnTrimmed -3.1%31 qtrs
Dodge & Cox2.7%$5.2bn$5.2bnTrimmed -3.4%32 qtrs
Harris Associates (Oakmark)0.1%$34.7m$34.7mTrimmed -32%53 qtrs
Matrix Asset Advisors0.0%$529k$529kUnchanged54 qtrs

Download the holders: CSV · JSON · Markdown

About the company

Sector
Consumer staples · Retail-Drug Stores And Proprietary Stores
Incorporated in
Delaware
Financial year ends
31 December
Shares outstanding
1.28bn at 29 Jul 2026
SEC filings
Annual reports and other filings on EDGAR

Revenue and profit

$127bn2013
$153bn2015
$185bn2017
$257bn2019
$292bn2021
$358bn2023
$402bn2025
2013: $127bn; 2014: $139bn; 2015: $153bn; 2016: $178bn; 2017: $185bn; 2018: $195bn; 2019: $257bn; 2020: $269bn; 2021: $292bn; 2022: $322bn; 2023: $358bn; 2024: $373bn; 2025: $402bn
CVS Health revenue and net income by year
YearRevenueNet income
2025$402bn$1.8bn
2024$373bn$4.6bn
2023$358bn$8.3bn
2022$322bn$4.3bn
2021$292bn$8.0bn
2020$269bn$7.2bn
2019$257bn$6.6bn
2018$195bn−$594m
2017$185bn$6.6bn
2016$178bn$5.3bn
2015$153bn$5.2bn
2014$139bn$4.6bn
2013$127bn–

From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.

Sold out last quarter

In fund portfolios

US-registered funds run by these managers that hold CVS Health, from their latest N-PORT filings.

Funds holding CVS Health
Davis Global FundDavis Selected Advisers4.0%$37.6m31 Jul 2026
Dodge & Cox Global Stock FundDodge & Cox1.9%$252m30 Jun 2026